Stress Management for Cardiovascular Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help women living with HIV in the Southern US manage stress and lower their risk of heart disease. The study tests an adapted version of the Stress Management and Resiliency Training Program, recognized for improving resilience and reducing stress-related health issues. Participants will either continue their usual care or try this new program. Women with HIV who speak English and receive care at the participating clinic might be a good fit. As an unphased trial, this study offers participants the opportunity to contribute to valuable research that could enhance stress management strategies for women with HIV.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on stress management for women living with HIV, so it's best to ask the trial organizers for more details.
What prior data suggests that the Stress Management and Resiliency Training Program is safe for women living with HIV?
Research has shown that the Stress Management and Resiliency Training (SMART) program is generally safe and manageable for most people. In past studies, participants felt significantly less stressed and noticed improvements in their mental health. No major negative effects have been reported from these activities, which use teaching and relaxation methods to reduce stress and anxiety. This suggests the program is quite safe for most people, including those at risk for heart disease.12345
Why are researchers excited about this trial?
Researchers are excited about the Stress Management and Resiliency Training Program for cardiovascular disease because it offers a non-drug approach to managing stress, which is a key factor in heart health. Unlike traditional treatments that often focus on medication to control blood pressure and cholesterol, this program emphasizes building mental resilience and coping skills. By teaching patients how to better handle stress, this method aims to address one of the root causes of cardiovascular issues rather than just treating the symptoms. This innovative focus on mental well-being could lead to more holistic and sustainable heart health improvements.
What evidence suggests that the Stress Management and Resiliency Training Program is effective for reducing cardiovascular disease risk among women living with HIV?
Research has shown that the Stress Management and Resiliency Training (SMART) program can lower stress and improve heart health. In this trial, participants will either receive the SMART program or continue with usual care. Studies have found that adding stress management to heart health programs results in less stress and better heart outcomes compared to standard care alone. The SMART program aims to increase psychological resilience, which is linked to a lower risk of heart disease and better overall health. Although researchers have not specifically tested this program on women with HIV in the Southern US, its success in different settings suggests it could help reduce stress-related heart risks for this group.36789
Are You a Good Fit for This Trial?
This trial is for women living with HIV in the Southern US, who are at higher risk for cardiovascular disease. It aims to help those dealing with stress-related health issues like high blood pressure and sleep apnea. Participants should be experiencing stressors such as poverty or discrimination that could impact their heart health.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the adapted SMART program intervention to reduce stress and mitigate cardiovascular disease risk
Follow-up
Participants are monitored for changes in resilience, blood pressure, depression, stress, and anxiety
What Are the Treatments Tested in This Trial?
Interventions
- Stress Management and Resiliency Training Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator